1. Home
  2. NEUP vs RMCO Comparison

NEUP vs RMCO Comparison

Compare NEUP & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUP
  • RMCO
  • Stock Information
  • Founded
  • NEUP 1996
  • RMCO 2021
  • Country
  • NEUP United States
  • RMCO United States
  • Employees
  • NEUP N/A
  • RMCO N/A
  • Industry
  • NEUP
  • RMCO Multi-Sector Companies
  • Sector
  • NEUP
  • RMCO Miscellaneous
  • Exchange
  • NEUP Nasdaq
  • RMCO Nasdaq
  • Market Cap
  • NEUP 12.7M
  • RMCO 14.9M
  • IPO Year
  • NEUP N/A
  • RMCO N/A
  • Fundamental
  • Price
  • NEUP $7.70
  • RMCO $1.48
  • Analyst Decision
  • NEUP Strong Buy
  • RMCO
  • Analyst Count
  • NEUP 1
  • RMCO 0
  • Target Price
  • NEUP $21.00
  • RMCO N/A
  • AVG Volume (30 Days)
  • NEUP 38.4K
  • RMCO 142.3K
  • Earning Date
  • NEUP 08-15-2025
  • RMCO 08-14-2025
  • Dividend Yield
  • NEUP N/A
  • RMCO 0.34%
  • EPS Growth
  • NEUP N/A
  • RMCO N/A
  • EPS
  • NEUP 0.00
  • RMCO N/A
  • Revenue
  • NEUP $15,662,715.00
  • RMCO $1,568,212.00
  • Revenue This Year
  • NEUP N/A
  • RMCO N/A
  • Revenue Next Year
  • NEUP N/A
  • RMCO N/A
  • P/E Ratio
  • NEUP $4,532.08
  • RMCO N/A
  • Revenue Growth
  • NEUP N/A
  • RMCO 204.08
  • 52 Week Low
  • NEUP $2.90
  • RMCO $0.76
  • 52 Week High
  • NEUP $126.00
  • RMCO $1.88
  • Technical
  • Relative Strength Index (RSI)
  • NEUP N/A
  • RMCO 49.79
  • Support Level
  • NEUP N/A
  • RMCO $1.18
  • Resistance Level
  • NEUP N/A
  • RMCO $1.37
  • Average True Range (ATR)
  • NEUP 0.00
  • RMCO 0.17
  • MACD
  • NEUP 0.00
  • RMCO -0.02
  • Stochastic Oscillator
  • NEUP 0.00
  • RMCO 13.43

About NEUP Neuphoria Therapeutics Inc. Common Stock

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.

About RMCO Royalty Management Holding Corporation

Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.

Share on Social Networks: